TScan Therapeutics, Inc. TCRX
0.14 USD -0.01 (-3.84%)
Regular-session close
0.15 +0.01 +4.98%
After hours · Nov 19, 6:41 PM ET
0.1401 Day range 0.157
0.14 52-week range 1.47
- YTD
- -85.73%
- 1 year
- -86.15%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 10.32M | 2.82M | 21.05M | 13.54M | 10.14M | |
| 10.32M | 2.82M | 21.05M | 13.54M | 10.14M | |
| -135.81M | -134.82M | -93.46M | -66.64M | -48.64M | |
| -129.77M | -127.50M | -89.22M | -66.22M | -48.63M | |
| -1.00 | -1.14 | -1.36 | -2.75 | -4.17 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 157.44M | 183.72M | 138.39M | 125.06M | 166.44M | |
| 228.79M | 371.12M | 272.15M | 199.09M | 188.11M | |
| 105.67M | 130.15M | 121.28M | 99.66M | 27.33M | |
| 94.14M | 97.38M | 92.43M | 85.98M | 6.04M | |
| 123.12M | 240.97M | 150.87M | 99.43M | 160.78M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -135.32M | -110.82M | -61.36M | -66.50M | -48.68M | |
| 109.37M | -52.61M | -60.76M | -4.22M | -9.94M | |
| -336.00K | 208.76M | 135.44M | 29.36M | 189.67M | |
| -4.41M | -3.83M | -3.15M | -4.22M | -9.94M | |
| -26.28M | 45.33M | 13.33M | -41.37M | 131.05M |
